¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"steroid myopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® steroid ÇÑ±Û ½ºÅ×·ÎÀ̵å
¼³¸í   
  Hydrogenated cyclopentanoperhydrophenanthrene ring systemÀ¸·Î ±¸¼ºµÈ ºÐÀÚ. »ýü³»¿¡¼­ Áß¿äÇÑ ½ºÅ×·ÎÀ̵å´Â ºÎ½Å°ÑÁú¿¡¼­ »ý¼ºµÇ´Â ½ºÅ×·ÎÀ̵å È£¸£¸óÀ̸破ç´ë»ç¿¡ °ü¿©Çϴ ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å(glucocorticoid), ¿°·ù´ë»ç(ÀÎü³» Á¸ÀçÇϴ ¿°ºÐ¼ººÐ(NaCl, KCl, NaOH µî)À» Á¶ÀýÇϴ ´ë»ç)¿¡ °ü¿©Çϴ ±¤¹°ÄÚ¸£Æ¼ÄÚÀ̵å(mineralocorticoid), ¼ºÈ£¸£¸ó(ÀÎüÀÇ ¼º¹ß´Þ¿¡ °ü¿©)ÀÇ ¼¼ °¡ÁöÀÌ´Ù.
  
  ½ºÅ×·ÎÀ̵å È£¸£¸óÀº ºÎ½ÅÇÇÁú¿¡¼­ ÄÝ·¹½ºÅ×·ÑÀ» Àç·á·Î ÇÏ¿© º¹ÀâÇÑ ÇÕ¼º´Ü°è¸¦ °ÅÃÄ ÇÕ¼ºµÈ´Ù. ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å´Â ³úÇϼöü¿¡¼­ ºÐºñµÇ´Â ºÎ½Å°ÑÁúÀڱؠȣ¸£¸ó(ACTH)¿¡ ÀÇÇØ »ý¼º°ú ºÐºñ°¡ ÀÌ·ç¾îÁö³ª ±¤¹°ÄÚ¸£Æ¼ÄÚÀ̵å´Â ·¹´Ñ-¾ÈÁö¿ÀÅٽŰè(½ÅÀå¿¡¼­ ÀÎü³» ¿°ºÐÀÌ ºÎÁ·½Ã ·¹´ÑÀÌ ºÐºñµÇ°í, ÀÌ ÀÚ±ØÀº ºÎ½ÅÀ¸·Î ÀüÇØÁ® ±¤¹°ÄÚ¸£Æ¼ÄÚÀ̵åÀΠ¾ÈÁö¿ÀÅÙ½ÅÀ» ºÐºñÇϰԠµÊ)ÀÇ Àڱؿ¡ ÀÇÇØ ºÐºñµÈ´Ù. ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å´Â transcortin°ú °áÇÕÇÏ¿© ¿î¹ÝµÇ¸ç ¹Ý°¨±â´Â Çѽð£ Á¤µµÀ̳ª ¿°·ùÄÚ¸£Æ¼ÄÚÀ̵å´Â ´ëºÎºÐÀÌ ´Ü¹éÁú°ú °áÇÕÇÏÁö ¾Ê°í À¯¸®ÇüÀ¸·Î ³²¾ÆÀ־ݰ¨±â´Â 20ºÐ¿¡ ºÒ°úÇÏ´Ù. À̵éÀÌ °£¿¡ µµ´ÞÇϸé glucuronic acid¿¡ °áÇÕÇÏ¿© ¹è¼³µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±Ù(À°)º´(Áõ)
  • mitochondrial myopathy
    »ç¸³Ã¼±Ù(À°)º´(Áõ)
  • myopathy
    ±Ù(À°)º´(Áõ)
  • adrenal steroid
    ºÎ½Å½ºÅ×·ÎÀ̵å
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • anabolic steroid
    ÇÕ¼º´ë»ç½ºÅ×·ÎÀ̵å
  • androgenic steroid
    ³²¼ºÈ­½ºÅ×·ÎÀ̵å
  • gonadal steroid
    »ý½Ä»ù½ºÅ×·ÎÀ̵å, ¼º¼±½ºÅ×·ÎÀ̵å
  • gonadal steroid-binding globulin
    »ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • steroid
    ½ºÅ×·ÎÀ̵å
  • steroid cataract
    ½ºÅ×·ÎÀ̵å¹é³»Àå
  • steroid cell tumor
    ½ºÅ×·ÎÀ̵弼Æ÷Á¾¾ç
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵åÀ¯¹ßÀ§Ãà
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myopathy
    ±ÙÀ°º´Áõ
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid
    ½ºÅ×·ÎÀ̵å
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±ÙÀ°º´Áõ
  • myopathy
    ±ÙÀ°º´Áõ
  • mitochondrial myopathy
    »ç¸³Ã¼±ÙÀ°º´Áõ
  • adrenal steroid
    ºÎ½Å½ºÅ×·ÎÀ̵å
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • anabolic steroid
    ´Ü¹éµ¿È­½ºÅ×·ÎÀ̵å
  • androgenic steroid
    ³²¼ºÈ­½ºÅ×·ÎÀ̵å
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵åÀ§Ãà
  • steroid cataract
    ½ºÅ×·ÎÀ̵å¹é³»Àå
  • gonadal steroid
    »ý½Ä»ù½ºÅ×·ÎÀ̵å
  • gonadal steroid-binding globulin
    »ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • steroid
    ½ºÅ×·ÎÀ̵å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
  • 17-ketogenic steroid
    17-ÄÉÅæÃ¼»ý¼º½ºÅ×·ÎÀ̵å
  • adrenal steroid
    ºÎ½Å½ºÅ×·ÎÀ̵å
  • adrenocortical steroid
    ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å
  • anabolic steroid
    ´Ü¹éµ¿È­Á¦
  • anabolic steroid
    ´Ü¹éµ¿È­½ºÅ×·ÎÀ̵å.
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • steroid myopathy
    ½ºÅ×·ÎÀ̵å±Ùº´Áõ(¡­Ü»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenal steroid
    ºÎ½Å½ºÅ×·ÎÀ̵å
  • adrenocortical steroid
    ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å
  • anabolic steroid
    ´Ü¹éµ¿È­Á¦
  • anabolic steroid
    ´Ü¹éµ¿È­½ºÅ×·ÎÀ̵å.
  • androgen, androgenic steroid
    ³²¼º(È­)È£¸£¸ó, ³²¼ºÈ­½ºÅ×·ÎÀ̵å.
  • cortical steroid
    ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å.
  • metabolic defect of steroid (adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±â?
  • steroid
    ½ºÅ×·ÎÀ̵å.
  • steroid acne
    ½ºÅ×·ÎÀÌµå ¿©µå¸§
  • steroid anesthetic
    ½ºÅ×·ÎÀ̵帶ÃëÁ¦.
  • steroid cataract
    ½ºÅ×·ÎÀ̵å¹é³»Àå
  • steroid folliculitis
    ½ºÅ×·ÎÀÌµå ¸ð³¶¿°
  • steroid glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid hormone
    ½ºÅ×·ÎÀ̵åÈ£¸£¸ó(ºÎ½ÅÇÇÁúÈ£¸£¸ó)((¡­Üùãìù«òõ¡­)
  • steroid psychosis
    ½ºÅ×·ÎÀ̵å Á¤½ÅÁõ(º´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenal cortical steroid
    ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • alcoholic steroid
    ¾ËÄݼº(àõ) ½ºÅ×·ÎÀ̵å
  • anabolic steroid
    µ¿È­´ë»ç(ÔÒûùÓÛÞó)½ºÅ×·ÎÀ̵å
  • cardiotonic steroid
    °­½É(Ë­ãý) ½ºÅ×·ÎÀ̵å
  • catatoxic steroid
    µ¶¼º¹æ¾î(Ô¸àõÛÁåÝ) ½ºÅ×·ÎÀ̵å
  • sex steroid binding plasma protein
    ¼º(àõ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê) Ç÷Àå(úìíì) ´Ü¹éÁú(úìíìÓ±ÛÜòõ)
  • steroid
    ½ºÅ×·ÎÀ̵å
  • steroid alkaloids
    ½ºÅ×·ÎÀÌµå ¾ËÄ®·ÎÀ̵å
  • steroid alkaloid saponin
    ½ºÅ×·ÎÀÌµå ¾ËÄ®·ÎÀÌµå »çÆ÷´Ñ
  • steroid conjugate
    ½ºÅ×·ÎÀ̵å Á¢ÇÕü(ïÈùêô÷)
  • steroid diabetes
    ½ºÅ×·ÎÀÌµå ´ç´¢º´(ÓØÒãÜ»)
  • steroid hormone
    ½ºÅ×·ÎÀ̵å È£¸£¸ó
  • steroid number
    ½ºÅ×·ÎÀÌµå ¹øÈ£(ÛãûÜ)
  • steroid receptor
    ½ºÅ×·ÎÀÌµå ¼ö¿ëü (áôé»ô÷)
  • steroid saponin
    ½ºÅ×·ÎÀÌµå »çÆ÷´Ñ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • steroid
    ½ºÅ×·ÎÀ̵å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCM Hypertrophic Cardio-Myopathy
  = HCMP
LIMM lethal infantile mitochondrial myopathy
MTM Thayer-Martin, modified [agar]; myotubular myopathy
MTMX myotubular myopathy, X-linked
XLMTM X-linked myotubular myopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CNM Centronuclear myopathy
MM Miyoshi myopathy
MTM1 Myotubular myopathy
PROMM Proximal myotonic myopathy
IIM idiopathic inflammatory myopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ
  • centronuclear myopathy
    Áß½ÉÇÙ ±Ùº´Áõ
    Áß¾Ó¿¡ ÇÙÀÌ ÀÖ´Â ±Ù¼¶À¯°¡ ÅÂ¾Æ ±Ù¼¶À¯ÀÇ Æ¯Â¡ÀÎ ±Ù¼¼°ü
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ
  • fingerprint body myopathy
    Áö¹® ¼Òü ±Ùº´Áõ
    ´ë´ÜÈ÷ µå¹® ÁúȯÀ¸·Î À¯¾Æ±âºÎÅÍÀÇ Àü½ÅÀû ±Ù ¼è¾à, À§Ãà, Àú±äÀåµµ¿Í Áö´É ÀúÇϰ¡ ³ªÅ¸³­´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ÀÛÀº À§ÃàµÈ ¼¶À¯¸¦ º¼ ¼ö ÀÖÀ¸¸ç ÀüÀÚÇö¹Ì°æ»ó¿¡¼­ ±Ù ¼¶À¯ÀÇ ¸·°ú ¼öÃà ¹°Áú »çÀÌ¿¡ ƯÀÌÇÑ ºÀÀÔü¸¦ º¸À̴µ¥ ÀÌ ºÀÀÔü´Â ¸·À¸·Î ½ÎÀÌÁö ¾Ê°í º¹ÀâÇÑ ÃþÆÇ ¹è¿­ÀÌ ¸¶Ä¡ Áö¹®°°ÀÌ º¸À̰í ÀÌ·¯ÇÑ ÃþÆÇµéÀº Åé´Ï °°Àº µ¹ÃâÀ» °®°í ÀÖ´Ù.
  • myotubular myopathy
    ±Ù ¼¼°ü¼º ±ÙÁõ
    ¼±Ãµ¼º ºñÁøÇ༺ ±Ù Àå¾Ö·Î ±Ù ¼¶À¯ÀÇ Á߽ɿ¡ ÀåÃàÀ» µû¶ó¼­ ÀÏ·Ä·Î ¹è¿­ÇÏ´Â Á᫐ ÇÙÀÌ ´ë´Ù¼öÀÇ ±Ù ¼¶À¯¿¡ ÀÎÁ¤µÇ´Â °ÍÀÌ Æ¯Â¡À¸·Î Å»ý±âÀÇ ±Ù°ü°ú À¯»çÇÑ Á¡¿¡¼­ ¸í¸íµÇ¾ú´Ù. Á᫐ ÇÙ ÁÖº¯¿¡ ±Ù¿ø¼¶À¯°¡ °á¿©µÈ ºÎºÐÀÌ ÀÖ´Â °æ¿ìµµ ÀÖ´Ù. ±Ù ±äÀå ÀúÇÏ, ¿îµ¿ ¹ß´ÞÀÇ Áö¿¬, ±Ù·Â ÀúÇÏ, ¾È°Ë Çϼö, ¾È¸é±Ù, ¿Ü¾È±Ù, °æ±Ù µîµµ ħ¹üµÈ´Ù. Ç÷û CPK´Â Á¤»óÀ̰ųª °æµµÀÇ »ó½ÂÀ» ³ªÅ¸³½´Ù.
  • nemaline myopathy
    ³×¸»¸°, °£¼Òü
  • adrenal steroid
    ºÎ½Å ½ºÅ×·ÎÀ̵å
  • anabolic steroid
    ´Ü¹é µ¿È­ ½ºÅ×·ÎÀ̵å
  • C19 steroid
    C19 ½ºÅ×·ÎÀ̵å
  • endogenous steroid
    ³»¿ø¼º ½ºÅ×·ÎÀ̵å
  • steroid
    ½ºÅ×·ÎÀ̵å
    ½ºÅ×·ÎÀ̵å ÇÙ C7H8À» °¡Áö´Â È­ÇÕ¹°. ÄÝ·¹½ºÅ×·Ñ, ´ãÁó»ê, È£¸£¸ó µî »ýü ³»¿¡¼­ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÏ´Â ¹°ÁúÀÌ Æ÷ÇԵȴÙ. ½ºÅ×·ÎÀ̵忡 ¼ÓÇÏ´Â È­ÇÕ¹°Àº ¿¹ÀüºÎÅÍ ¾Ë·ÁÁ® ÀÖ¾úÀ¸³ª 20¼¼±â ÃʺÎÅÍ °èÅëÀûÀÎ ¿¬±¸°¡ ÃßÁøµÇ¾î, 1932³â O. ·ÎÁ¨ÇÏÀÓ, H. Å·, H.O. ºô¶õÆ®°¡ ¸ðµÎ ½ÃŬ·Î ÆæÅ¸ ³ëÈ÷µå·ÎÆä³­Æ®·» °í¸®¸¦ °®´Â´Ù´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù. ½ºÅ×·ÎÀ̵å°èÀÇ ¼º È£¸£¸óÀº »ýü ³»¿¡¼­ ±æÇ×Àû ¶Ç´Â Çùµ¿ÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸öÀÇ Á¶ÀýÀ» À¯ÁöÇϰí Àִµ¥, ±¸Á¶»ó À¯»çÇÏ´Ù´Â °Í¸¸À¸·Î´Â ±× ÀÛ¿ëÀ» ¼³¸íÇÒ ¼ö ¾ø´Ù. µð¿¡Æ¿ ½ºÆ¿º£½ºÅç°ú °°Àº ÇÕ¼º ¾àǰµµ °­ÇÑ ¹ßÁ¤ È£¸£¸óÀÇ ÀÛ¿ëÀ» º¸ÀÌ´Â °ÍÀÌ ÀÖ¾î ³Î¸® ½Ç¿ëÈ­µÇ°í ÀÖ´Ù. ¶Ç ÄÚ¸£Æ¼¼Õ µî ºÎ½Å ÇÇÁú È£¸£¸ó¿¡´Â °­ÇÑ Ç׿°Áõ ÀÛ¿ëÀÌ ÀÖ¾î ÀǾàǰÀ¸·Î »ç¿ëµÇ°í ÀÖ´Ù. ´ãÁó»êÀº ¼ÒÈ­±â ³»¿¡¼­ ¹°¿¡ ³ìÁö ¾Ê´Â À½½Ä¹°À» ³ìÀ̸ç, ¼ÒÈ­, Èí¼ö¸¦ ½±°Ô ÇØÁÖ´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖÀ¸³ª ±× ÀÛ¿ë¿¡ ´ëÇØ¼­´Â Àß ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù.
  • steroid anesthetic
    ½ºÅ×·ÎÀÌµå ¸¶ÃëÁ¦
  • steroid cover
    ½ºÅ×·ÎÀ̵å ÇǺ¹
  • steroid rebound phenomenon
    ½ºÅ×·ÎÀÌµå ¹Ýµµ Çö»ó
  • steroid therpay
    ½ºÅ×·ÎÀÌµå ¿ä¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
carcinomatous myopathy <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness.
(27 Sep 1997)
centronuclear myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
rod myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
myopathy <neurology> Any disease of a muscle.
Origin: Gr. Pathos = disease
(18 Nov 1997)
myotubular myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
nemaline myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
ocular myopathy A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
thyrotoxic myopathy Extreme muscular weakness in severe thyrotoxicosis affecting muscles of limbs and trunk as well as those used in speech and swallowing.
(05 Mar 2000)
anabolic steroid <endocrinology> A type of steroid hormone that stimulates the synthesis of protein. Anabolic steroids are compounds which stimulate the body into anabolism. This process involves the building of complex compounds from smaller simpler ones (for example proteins are built from amino acids). This process requires energy.
(13 Nov 1997)
receptors, steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behaviour of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes.
(12 Dec 1998)
gonadal steroid-binding globulin A protein that transports 65% of the testosterone in plasma.
Synonym: sex steroid-binding globulin.
(05 Mar 2000)
saturated steroid 6 alpha-hydroxylase <enzyme> Acts on 5 alpha-androstane-3 beta,17 beta-diol and 5 alpha-pregnan-3 beta-ol-20-one; does not require cytochrome p-450
Registry number: EC 1.14.99.-
Synonym: sat steroid 6alpha-hydroxylase
(26 Jun 1999)
sex steroid-binding globulin A protein that transports 65% of the testosterone in plasma.
Synonym: sex steroid-binding globulin.
(05 Mar 2000)
steroid A group name for lipids that contain a hydrogenated cyclopentanoperhydrophenanthrene ring system. Some of the substances included in this group are progesterone, adrenocortical hormones, the gonadal hormones, cardiac aglycones, bile acids, sterols (such as cholesterol), toad poisons, saponins and some of the carcinogenic hydrocarbons.
(18 Nov 1997)
steroid 11-alpha-hydroxylase <enzyme> Converts 11-deoxycortisol to 11-alpha cortisol (the 11-alpha isomer of hydrocortisone)
Registry number: EC 1.14.99.-
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • steroid
    ½ºÅ×·ÎÀ̵å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á